(AP)—From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether ...
Jan 4, 2013
0
0
Australian drugmaker CSL Ltd. said Monday it will buy Novartis' flu vaccine business for $275 million.
Oct 27, 2014
0
0
Europe's top drug regulator has recommended approval for the first vaccine against meningitis B, made by Novartis AG.
Nov 16, 2012
0
0
(AP)—Swiss pharmaceutical company Novartis AG reported a 6.7 percent increase in profit for the first quarter Wednesday, boosted by new products and emerging markets.
Apr 24, 2013
0
0
Swiss pharmaceutical firm Novartis AG launched a major overhaul of its business Tuesday, unveiling a series of multibillion-dollar deals with Britain's GlaxoSmithKline PLC and the U.S.'s Eli Lilly & Co. that heralds more ...
Apr 22, 2014
0
0
Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends contributed to ...
Oct 22, 2013
0
0
(AP)—Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous year.
Jan 23, 2013
0
0
Swiss pharmaceutical company Novartis AG posted a 3 percent rise in second-quarter profits Thursday, reflecting what it described as solid growth and an increased focus on core products.
Jul 17, 2014
0
0
Europe's drug regulator says there is no proof that a flu vaccine for the elderly was linked to side effects, including deaths in Italy.
Dec 3, 2014
0
0
Swiss pharmaceutical giant Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit.
Jan 27, 2015
0
5
